Menu
FDA · Drug recall

Licorice Coughing Liquid (guaifenesin)…

June 1, 2016 Class I

Date
June 1, 2016
Risk class
Class I (FDA's definition, 21 CFR 7.3(m): a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death)
Status
Terminated
Filed by
Master Herbs, Inc./Li
Product
Licorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC, Manufactured by: Ma Ying Long Pharmaceutical Group Co., LTD, Wuhan, China; Distributed by: Master Herbs (USA) Inc., NDC 68511-0460-01
Reason
Marketed Without An Approved NDA/ANDA: presence of undeclared morphine.
Distribution pattern
Nationwide
Quantity
6024 bottles
Codes and lots
all lots
Recall started
Jan. 15, 2016
Recall number
D-0908-2016

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0908-2016. The agency record governs; check it and the company before acting.

Report a mistake on this page